000 | 01865 a2200517 4500 | ||
---|---|---|---|
005 | 20250514232817.0 | ||
264 | 0 | _c20051213 | |
008 | 200512s 0 0 eng d | ||
022 | _a1098-4275 | ||
024 | 7 |
_a10.1542/peds.2004-2553 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRojas-Marcos, Patricia Martin | |
245 | 0 | 0 |
_aHormonal effects in infants conceived by assisted reproductive technology. _h[electronic resource] |
260 |
_bPediatrics _cJul 2005 |
||
300 |
_a190-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_a17-alpha-Hydroxyprogesterone _xblood |
650 | 0 | 4 |
_aAdrenal Hyperplasia, Congenital _xdiagnosis |
650 | 0 | 4 | _aAge Determination by Skeleton |
650 | 0 | 4 |
_aAndrostenedione _xblood |
650 | 0 | 4 |
_aBreast _xgrowth & development |
650 | 0 | 4 |
_aChorionic Gonadotropin _xadministration & dosage |
650 | 0 | 4 |
_aChorionic Gonadotropin, beta Subunit, Human _xblood |
650 | 0 | 4 |
_aDehydroepiandrosterone Sulfate _xblood |
650 | 0 | 4 |
_aEstradiol _xblood |
650 | 0 | 4 |
_aEstrone _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFertilization in Vitro _xadverse effects |
650 | 0 | 4 |
_aFollicle Stimulating Hormone _xadministration & dosage |
650 | 0 | 4 |
_aHair _xgrowth & development |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOvulation Induction _xadverse effects |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPuberty, Precocious _xblood |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 |
_aReproductive Techniques, Assisted _xadverse effects |
650 | 0 | 4 |
_aTestosterone _xblood |
700 | 1 | _aDavid, Raphael | |
700 | 1 | _aKohn, Brenda | |
773 | 0 |
_tPediatrics _gvol. 116 _gno. 1 _gp. 190-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1542/peds.2004-2553 _zAvailable from publisher's website |
999 |
_c15651896 _d15651896 |